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IntroductIon
Inflammation is part of the complex biological re-
sponse of vascular tissues to harmful stimuli, such as 
pathogens, damaged cells, or irritants1. Inflammation 
is not a synonym for infection, even in cases where 
inflammation is caused by infection. Although infec-
tion is caused by a microorganism, inflammation is 
one of the responses of the organism to the pathogen. 
Additional causes of inflammation are burns, chemi-
cal irritants, frostbite, toxins, physical injury, blunt or 
penetrating, immune reactions due to hypersensitivity, 
ionizing radiation, and foreign bodies.
Inflammation can be classified as either acute or 
chronic, local or systemic. Acute-local inflammation 
lasts from few minutes up to some days. Its classic 
signs and symptoms are redness, swelling, heat, pain, 
loss of function. All the above signs may be observed 
in specific instances, but no single sign must, as a mat-
ter of course, be present. Apart from loss of function 
these are the original, or “cardinal signs” of inflamma-
tion. Loss of function is an apocryphal notion, as it is 
not unique to inflammation and is a characteristic of 
many disease states. On the contrary, chronic-systemic 
inflammation can endure a longer period of time and it 
can be the result of acute inflammation2,3,4. 
PathoPhysIologIcal  
mechanIsm of InflammatIon
Changes in vascular caliber and blood flow
As soon as injury occurs there is often a transient va-
soconstriction that takes place. Nevertheless, this is 
rapidly followed by vasodilation of the local blood 
vessels with consequent excess local blood flow. 
Many previously unopened capillaries open and that 
can lead to increased blood flow up to tenfold. How-
ever, the rate of flow through the still dilated vessels 
gradually decreases5. The increase of local blood flow 
is of great importance because it regulates to a large 
extent the amount of exudates. If for example local 
blood flow is temporarily stopped exudates will be re-
duced or abolished6.
Increased vascular permeability
Under normal circumstances, small blood vessels in 
most tissues are fully permeable to water and wa-
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ter soluble small molecules but not quite permeable 
to plasma proteins. During inflammation increase in 
vascular permeability practically means increase in 
the permeability of plasma proteins, such as albumin. 
This leakage after local injury can occur through two 
different distinct mechanisms: a) directly as a result 
of the harmful agent itself (heat, mechanical trauma) 
b) indirectly from the release of chemical mediators in 
the absence of tissue damage. Direct injury can affect 
all types of vessels whereas indirect injury shows a 
high degree specificity for the venules. 
In order to understand the two mechanisms men-
tioned above, we must proceed to examine the cellular 
mechanisms of such leakage. It is established that the 
main permeability barrier is the vascular endothelium. 
In fact, there are different models which explain how 
the endothelial layer leaks. The simplest one is the so-
called endothelial destruction after exposure with the 
harmful agent. Cells break up or die whereas the base-
ment membrane remains. When this happens, platelets 
adhere to the damaged surface but do not manage to 
obliterate the vascular lumen. Another cellular mecha-
nism has to do with the formation of gaps by unzip-
ping of the endothelial junctions. It often takes place 
in mild, direct injuries, as if the intracellular junctions 
are particularly delicate. Finally, the main and most 
complicated mechanism is the formation of intercel-
lular gaps by endothelial contraction. This contraction 
results from activation of muscular elements within 
endothelial cells, which pull away from each other5,6. 
The process lasts about 15-30 minutes, it is revers-
ible and takes place in venules, but not capillaries or 
arterioles. Many different endogenous factors, called 
mediators, such as bradykinin, histamine, C3, C5a 
participate in this procedure (see further). 
As far as the term transcellular canal is concerned 
it appears that such canals exist in normal endothe-
lium and they could increase in size under pathologic 
conditions. However, scanning electron microscopic 
observations show that most of the openings in leaky 
venules are intercellular gaps, not transcellular holes. 
The formation and closure of gaps are likely to be 
energy-dependent. Nevertheless, the cellular mecha-
nisms of gap opening and closure remain to be elu-
cidated7.
Cellular events (leukocytic infiltration)
The tissue macrophage is the first line of defense 
against the harmful stimuli. Right after the beginning 
of inflammation the tissue macrophages, whether his-
tiocytes in the subcutaneous tissues begin their phago-
cytic actions. These cells usually enlarge their size in 
order to achieve their mission, when activated by the 
products of inflammation. They break loose from their 
attachments and become mobile. During this first mo-
bilization, the number of macrophages taking part is 
not great. 
Neutrophil invasion into the inflamed area is a sec-
ond line of defense. Within the first hour after inflam-
mation begins, neutrophils invade the inflamed area 
from the blood. Different products from the inflamed 
tissues alter the inside surface of the endothelium 
leading neutrophils to stick to the capillary walls. This 
is achieved through various adhesion molecules such 
as selectins and integrins. The phenomenon is called 
margination. On the other hand direct adhesion is ex-
tremely rare. Soon after the adhesion on the endothe-
lium surface, leukocytes extend pseudopodia and pass 
through gaps between endothelial cells. This is called 
diapedesis. Other products of the inflammatory pro-
cess participate to the activation and chemoattraction 
of neutrophils, for example IL-8,leukotrienes (see 
further)8,9.
The third line of defense consists of the second 
invasion of the macrophages in the inflames tissue. 
This constitutes a very important phenomenon as 
macrophages have a much stronger phagocytic abil-
ity compared to neutrophils themselves. However, 
this second invasion requires a much more lengthy 
process, as monocytes require over 8 hours in the in-
flamed tissue to swell to larger sizes and express their 
phagocytic mission. In addition, the storage pool in the 
bone marrow is much less than that of neutrophils.
The fourth line of defense includes the produc-
tion of granulocytes and monocytes by the bone mar-
row. However it can take up to 3 or 4 days until the 
newly formed cells are able to leave the bone mar-
row. This procedure is induced by a large variety of 
biological factors. Nevertheless, these which seem to 
play the most significant role are tumor necrosis fac-
tor (TNF),interleukin-1 (IL-1), GM-CSF, G-CSF and 
M-CSF. The combination of all factors seems to pro-
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vide a powerful feedback mechanism which gradually 
leads to the removal of the cause of inflammation9. 
Biological factors and mediators  
during inflammation
There is a large number of mediators and chemoat-
tractants during inflammation. Mediators can be di-
vided in two basic categories: plasma derived media-
tors and cell derived mediators. During this article we 
will try to focus to those which seem to play the most 
important role in the inflammatory process.
Plasma derived mediators
Bradykinin
Bradykinin is a mediator produced by the kinin sys-
tem. It is a peptide which has multiple functions and 
effects. There are two subtypes of bradykinin recep-
tors, B1 and B2 (BDKRB1 and BDKRB2). The B1 
receptor encoding is regulated following tissue injury 
and inflammation. The respective gene contains three 
exons separated by two introns10. Receptor binding in-
creases the cytolytic calcium ion concentration result-
ing in acute and chronic inflammations11. B1 receptor 
seems to play an important role in the initiation and 
maintenance of pain. That’s why bradykinin inhibitors 
are being developed as pain-reducing agents in animal 
models. Some studies show that these B1 receptor-an-
tagonists have no analgesic effect for incision induced 
pain12. Moreover, B1 receptor plays a functional role 
in the processes regulating the initial steps of leu-
kocyte extravasation and leukocyte trafficking. The 
B1 receptor activation induces interactions between 
circulating leukocytes and the venular endothelium 
leading to leukocyte emigration from postcapillary 
venules13.
The B2 receptor is related with bradykinin’s vaso-
dilatory role. Studies in dogs showed that the B2 re-
ceptor activation increases the vascular permeability 
and blood flow. This seems to be achieved through the 
release of an endothelium-dependent relaxing factor 
that may be nitric oxide14. 
C3
C3 is a protein of the immune system which plays a 
central role in the complement system. C3 cleaves to 
produce C3a and C3b. Receptors to C3a are expressed 
in many cells such as leukocytes, platelets, mast cells 
and astrocytes. Only one form of C3aR has been de-
tected in human. C3a induces more unique or different 
signaling events in eosinophils, and perhaps mono-
cytes, than it does in neutrophils despite the presence 
of C3a receptors on each of these cell types. Earlier it 
was widely thought that C3a can induce degranulation 
,aggregation and chemotaxis of human neutrophils. 
However, recent studies show that the eosinophils 
stimulated by C3a release factors are able to stimu-
late neutrophils. C3a also activates mast cells render-
ing them capable of releasing histamine which causes 
vasodilation during inflammation. However, studies 
show that the primary site for C3a on the mast cell is 
the enzyme chymase. In other words, mast cell activa-
tion by C3a appears to be C3aR-independent15.
C3b interacts with complement receptor 1, (CR1) 
functioning as an opsonin for phagocytes. It is able to 
bind to bacterial cell walls and marks the invader as 
a target for phagocytosis16. C3b cleaves C5 into C5a 
and C5b.
C5a
C5a plays a very important role in the development 
of many inflammatory diseases such as rheumatoid 
arthritis, lupus, sepsis, lung injury etc. C5a was first 
described as an anaphylatoxin able to cause rapid re-
lease of histamine and tryptase from mast cells and 
chemoattract macrophages during inflammation. 
Nowadays it is thought to have multiple function. It 
is considered a pleiotropic molecule as all cells of 
the myeloid lineage can be stimulated by C5a. There 
are two receptors for C5a. In neutrophils C5a leads 
to activate the p21-activated kinases (PAK). The PAK 
family members are involved in altering the cell mor-
phology and chemotaxis. Moreover, C5a activates the 
transcription factor cAMP response element binding 
protein (CREB). CREB activation has been proposed 
to be a part of the mechanism by which C5a can delay 
neutrophil apoptosis and prolong an inflammatory re-
sponse. The development of effective small molecule 
antagonists for C5a receptors is an attractive alterna-
tive. The usage of such compounds has offered a lot 
of help in order to understand how C5a gets involved 
in the inflammatory process. Nevertheless, although 
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C5aR antagonists may be beneficial for some existing 
inflammatory conditions they can also have some side 
effects, for example despite their protective role in the 
sensitization phase of asthma, they can make patients 
become more easily sensitized to new pulmonary al-
lergens17.
Hageman Factor (Factor XII)
Among coagulation factors it seems to be playing the 
most important role during inflammation. The Hage-
man factor normally exists inactive in plasma and is 
encoded by the F12 gene. A mutation in this gene can 
lead to factor XII deficiency. However, it remains un-
clear why people with such a deficiency do not expe-
rience abnormal bleeding like those with deficiencies 
of other coagulation factors. Of course, such patients’ 
blood takes longer to clot18. 
The activated, due to endothelium damage, plate-
lets release inorganic polyphosphate that directly bind 
and activate the Hageman factor. The activated factor 
can stimulate the kinin system and lead to bradyki-
nin production which causes vascular permeability 
and pain as mentioned above. Through the intrinsic 
pathway of coagulation the factor initiates fibrin for-
mation which is important for thrombus formation. In 
addition, Hageman factor stimulates plasmin, able to 
break down fibrin clots19. Experiments conducted in 
mice show that cultured hepatocytes transcribe, syn-
thesize and secrete authentic factor XII20.
Thrombin
Thrombin is a serine protease that plays a signifi-
cant role in the coagulation procedure. It cleaves fi-
brinogen to insoluble fibrin. Thrombin is considered 
a polyfunctional tool during inflammation. It induces 
the activation of factors V, VIII, XI and platelet ag-
gregation. Many cells participating in tissue repair 
such as monocytes, T-lymphocytes mast and nervous 
cells are stimulated by thrombin. Thrombin has the 
ability to release nitric oxide and prostacyclin from 
endothelial cells and cause vasodilation. The PAR-1 
receptors of thrombin play an important role to the in-
flammatory process. The activation of such receptors 
can trigger many various transducing systems. It also 
stimulates the expression of IL-8 in human mono-
cyte cell culture and expression of IL-6 and G-CSF 
in fibroblasts. Thrombin can activate adhesion and ag-
gregation of platelets, release of growth factors from 
cells, adhesion and recruitment of leukocytes. Various 
studies show that thrombin can somehow interact with 
mast cells. However, little is known about how this 
is achieved. Thrombin causes degranulation of mast 
cells during inflammation. This may be mediated by 
stimulation of mast cell PAR-1 receptor. The latter is 
not yet proved but requires further experimental stud-
ies. In conclusion, thrombin functions as a conductor 
of cell responses during inflammation and reparative 
processes in tissues21.
Cell derived mediators
Histamine
Histamine is the most significant vasoactive amine 
during inflammation. It is secreted by mast cells, 
platelets and basophils. Histamine performs its action 
by combining with special histamine-receptors. There 
are four types of such receptors, H1-H4 receptors. 
Every cell type expresses at least one of these recep-
tors. Former studies showed that the only exception 
had to do with mast cells as it was thought that such 
cells could not express any receptors. H1 receptors 
can trigger a number of intracellular events character-
ized by changes in free cytosolic calcium levels. Such 
functions take place during smooth muscle contrac-
tion and separation of endothelial cells. Stimulation 
of H2 receptors results to elevation of cAMP, leading 
to vasodilation22. H3 receptors are mostly located in 
the central nervous system. Their function leads to de-
creased neurotransmitter release such as serotonin and 
acetylcholine and final inhibition of cAMP23. In oppo-
sition to what was formerly believed, H4 receptors are 
expressed in mast cells. Through these receptors, his-
tamine causes chemotaxis of mast cells. Their func-
tion is also related to decrease in cAMP24. As men-
tioned above, histamine is mainly released by mast 
cells and platelets. The pathophysiologic mechanism 
of this is immunologic. These cells are sensitized by 
IgE antibodies which are attached to their membranes 
and they degranulate. Histamine is finally released 
from mast cells’ cytoplasmic granules25.
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Interferon-gamma (IFN-γ)
Interferon Gamma is also called immune or type II in-
terferon. It has the ability to regulate nearly all phases 
if immune and inflammatory responses. In contrast 
to type I interferons IFN-γ is more important as an 
immunoregulator than as an antiviral agent. It in-
creases the cytotoxic activity of T cells, macrophages 
and natural killers. It also seems to be enhancing the 
antigen-presenting function of macrophages26. IFN-γ 
is secreted from CD4+ and CD8+ T cells and Natu-
ral Killers. It is IL-2 and IL-12 which stimulate such 
cells to produce IFN-γ. The most necessary step of the 
IFN-γ biochemical pathway is the interaction with the 
receptors located on the surface of the cells. There is 
actually an IFN Receptor complex, consisting of two 
alpha chains and two beta chains. Signal transduction 
is mediated by Jak1, Jak2 and STAT1a which initi-
ates the transcriptional events27. IFN-γ enhances the 
microbicidal function of macrophages through forma-
tion of nitric oxide. It promotes the differentiation of 
naïve helper T cells into Th1 cells. Interferons are used 
therapeutically by injection in the blood stream. The 
main priority of clinical research for the future is the 
combination of interferons with other drug therapies.
TNF-a
TNF-a is a cytokine involved in systemic inflammation 
and is a member of a group of cytokines that stimu-
late the acute phase reaction. TNF-a has multiple roles 
such as regulation of immune cells, inflammation and 
apoptotic cell death. During the inflammatory process 
TNF-a is mainly secreted by macrophages or mono-
cytes that can induce the necrotic cell death. TNF-a 
can proliferate and differentiate many types of cells. 
This cytokine can trigger many similar inflammatory 
reactions such as fever or activation of fibroblasts. It 
can function as a pyrogen through direct action or by 
stimulation of IL-1 secretion. All these actions are 
performed by TNF-a through specific members of 
the TNF receptor superfamily. Two receptors can be 
found by TNF-a. TNF-R1 is expressed in most tissues, 
whereas TNF-R2 is located only in cells of the im-
mune system.
Once TNF-a binds with the correspondent recep-
tor, the receptors form trimers. This binding enables 
an adaptor protein called TRADD and that’s how three 
pathway can be initiated: activation of NF-kB, activa-
tion of the MAPK pathways, induction of death signal-
ing. TNF-R1 is involved in death signaling. However, 
during the inflammatory process TNF-a plays only a 
minor role as far as the latter is concerned. TNF-a is 
also produced by lymphoid cells, mast cells and en-
dothelial cells28. 
IL-1,IL-8
Interleukin-1 is a cytokine with a wide spectrum of 
metabolic activities. It binds to the IL-1 receptor. 
There are two types of IL-1, IL-1a and IL-1b. IL-1a is 
mostly known for its synergism with TNF-a as men-
tioned above. There are only few cases of its action 
where such a synergism has not been detected. IL-1a 
mainly induces TNF-a release by endothelial cells and 
causes proliferation of smooth muscle cells.
IL-8 is mainly secreted by macrophages and works 
as a chemotactic factor. IL-8 attracts neutrophils at 
the site of inflammation. Neutrophil infiltration into 
inflammatory sites is one of the hallmarks of acute in-
flammation29. In neutrophils, IL-8 can induce increase 
of intracellular calcium, exocytosis, respiratory burst. 
IL-8 can have a weak impact on monocytes and eo-
sinophils. The molecular mechanism in which IL-8 
is involved to mediate its signal is the induction of 
NF-kB through a unique pathway in a similar way as 
TNF-a30.
Nitric oxide
Nitric oxide plays an important role in various bio-
logical systems. It is synthesized from the amino-acid 
L-arginine via the enzyme nitric oxide synthase. Such 
synthases are widely expressed in a large variety of 
cells such as immune cells but also from cells outside 
the classical immune system. The main stimuli for 
nitric oxide synthases induction include interferon-γ, 
TNF-a and other mediators of inflammation. 
During inflammation nitric oxide is known as the 
endothelium-derived relaxing factor. It can oxidate 
the iron containing proteins and activate the enzyme 
leading to cyclic guanosine monophosphate forma-
tion, cGMP. High levels of cGMP are responsible for 
many cellular actions of NO, such as muscle relax-
ation, platelet aggregation and adherence. Induced 
macrophages can produce large amounts of NO and 
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this can have a direct impact on DNA of target cells, 
resulting to fragmentation.
Another important chemical reaction during in-
flammation is this between NO and O
2 
- . As a result, 
peroxynitrite, OONO- is produced. OONO- is a potent 
oxidant and can lead to production of free radicals. 
This can cause a number of effects on cells such as 
modification of structural proteins and lipid peroxida-
tion of membranes31.
Nitric oxide is considered an antianginal drug. It 
causes vasodilation and decreases the amount of vol-
ume that the heart has to pump.
methods of detectIon  
of BIologIcal factors
There Is a large number of methods to detect the bio-
logical factors mentioned above. However, we will try 
to focus to the most significant and the most widely 
accepted.
Bradykinin
A quite sensitive technique for detecting and quan-
titating fluorescamine-labeled kinins and their prod-
ucts is the high performance liquid chromatography. 
Bradykinin is labeled with fluorescamine subjected to 
the chromatography and was scanned for the fluores-
cence signal with excitation at 390 nm and emission 
at 476 nm. During this process a system of methanol-
triethylammonium formate buffer is used, in order to 
separate the fluorescamine-labeled kinins. Labeled 
kinins are eluted in the following order: bradykinin, 
Lys-bradykinin, Met-Lys-bradykinin. At the same 
time, unlabeled kinins can be subjected to high per-
formance chromatography and the order of elution is 
Lys-bradykinin, bradykinin and Met-Lys-bradykinin. 
These two different patterns provided with these two 
different methods is a way to identify purified brady-
kinins. The fluorescamine label is a much more sen-
sitive method to detect bradykinin and its metabolic 
products32. 
There are of course various other methods for the 
quantitative determination of bradykinin in blood 
samples such as the ELISA, which has been developed 
as an enzyme linked immunosorbent assay. According 
to the latter, bradykinin in a sample and peroxidase 
labeled bradykinin are allowed to react competitively 
to anti-bradykinin antibody captured by anti-rabbit 
IgG antibody coated in microstrip wells. Bradykinins 
concentration is determined from the enzyme activity 
of peroxidase labeled bradykinin bound to anti-brady-
kinin antibody.
High levels of Bradykinin can be measured in vari-
ous situations such as acquired and hereditary angio-
oedema.
C3
In the past, different methods were used to detect C3. 
C3 bound to sheep erythrocytes reacts with anti-C3 
antibody. This complex can be detected quantita-
tively by the grade of lysis which occurs when whole 
complement is added to it. The C3 to be measured is 
added to a standard amount of anti-C3 antibody. The 
absorbed antiserum is infused to sheep erythrocytes 
and then the lysis takes place after adding pig comple-
ment. The results are compared with the curves ac-
quired by known C3 antigen. This method can detect 
even very low concentrations of bound C333. 
Uncleaved C3 and its fragments, C3a and C3b can 
be detected using monoclonal antibodies through the 
development of sandwhich-enzyme-linked immuno-
sorbent assays. The ELISA method can be used to 
detect uncleaved C3 in human plasma, whereas the 
addition of EDTA in plasma is used to detect C3a and 
C3b fragment. This method has a high grade of sensi-
tivity and specificity. The detection limits for both C3 
and C3a are 1ng/ml34. 
C3b can be detected through real time techniques. 
A reaction between antigen and antibody takes place 
on a reflective surface within a flow cell. This im-
munoreaction occurs between mouse monoclonal 
antibody and known concentrations of purified C3b 
in human serum. The rate of the signal changes is 
monitored during the first 60 seconds of the reaction. 
Through this method the lowest detectable concentra-
tion of C3b is 20ng/ml35.
Levels of C3 may be measured to support or re-
fute a particular medical diagnosis. For example, low 
levels of C3 are associated with some types of kidney 
disease, such as post-infectious glomerulonephritis 
and shunt nephritis.
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C5a
The usual method to detect C5a is the ELISA method 
using monoclonal antibodies, in the same way the 
method detects C3a and C3b as mentioned above.34 
However, the direct quantitation of C5a/C5a-desArg 
in human plasma was achieved through the ELISA 
method, using the specific monoclonal antibody 
C17/5. C5a-desArg is a metabolite of C5a which is a 
much less potent anaphylatoxin. The antibody C17/5 
blocks the binding of C5a/C5a-desArg to its cellular 
receptors and that’s why it can provide useful infor-
mation as far as the action of C5a is concerned, in 
complex biologic systems. The lowest detection limit 
of C5a using this method is 20pg C5a/ml plasma36. 
In order to quantify C5a/C5a-desArg in bovine 
biological fluids using the ELISA method with mono-
clonal antibodies, zymosan can be used. Zymosan is 
a potent activator of the complement cascade, used to 
generate C5a/C5a-des Arg37.
C5a is worth to be measured in cardiac anaphy-
laxis, psoriasis and atopic dermatitis.
Hageman factor (Factor XII)
The two main methods for the detection and the quan-
titation of the Hageman factor are the immunobinding 
assay and the ELISA method. For the quantitification 
of factor XII, an immunobinding assay on nitrocel-
lulose has been developed. Plasma samples are dot-
ted on nitrocellulose filters and the Hageman factor 
is detected using a radiolabelled antigen overlay. The 
radioactivity of the bound with I125 Hageman factor is 
used for its quantitification. Normal human plasma 
or purified factor in to factor XII deficient plasma 
are used as standards. This method can detect factor 
XII concentration corresponding to 1% of the level in 
normal human plasma. The advantages of the immu-
nobinding assay are the fast quantitification of large 
number of samples and its high sensitivity38.
The ELISA method employing 2/215 mouse mono-
clonal antibody has been used to detect the activated 
Hageman factor in patients with renal failure, preg-
nancy and diabetes compared to a control group39.
The main indication of measuring factor XII is to 
diagnose the Hageman factor deficiency. This disor-
der is thought to be benign and usually presents no 
symptoms.
Thrombin
Thrombin can be detected through different nanoma-
terial and thrombin-aptamer based detection methods. 
Such methods usually use cerium oxide nanoparti-
cles40. However, there is also a label-free, colorimetric 
assay, using gold nanoparticles and fibrinogen. When 
fibrinogen is added into a solution of gold nanopar-
ticles electrostatic and hydrophobic interactions take 
place, leading to the formation of agglutinations. In 
the presence of excess fibrinogen, the addition of 
thrombin induces the formation of insoluble fibrillar 
fibrin-gold nanoparticles. This occurs through the po-
lymerization of the conjugated and unconjugated fi-
brinogen. High concentrations of thrombin, decrease 
the absorbance of the supernatant after centrifugation 
and that’s how the quantitative detection of thrombin 
is achieved. The last method can provide lower limits 
of detection comparing to the aptamer based detection 
methods41.
The ELISA method has been used in order to detect 
thrombin-hirudin complex and thrombin-antithrombin 
complex in plasma and in purified systems42,43. 
Thrombin must be measured to detect any acquired 
or genetic thrombotic disorder or support the develop-
ment of antithrombotic drugs.
Histamine
Histamine can be determined in plasma by liquid 
chromatography and electrochemistry. The method is 
based upon deproteination of plasma. Plasma proteins 
are precipitated by adding concentrated perchloric 
acid. After centrifugation, the deproteinized supernate 
is adjusted to ph 7.5. Standards containing histamine 
and 3-methylhistamine are used as standards and are 
prepared in the same way. The samples are then pu-
rified on cation-exchange resin. The eluate is evapo-
rated and histamine in the sample is condensed with 
o-phthalaidehyde and 2-mercaptoethanol at ph 11.5. 
The adduct is then separated with liquid chromatogra-
phy and detected electrochemically. This method pro-
vides high sensitivity in the quantitation of histamine. 
In contrast to radioenzymatic assay the technique re-
quires no histamine N-methyltranferase. The method 
can determine histamine in 25 plasma samples once 
they have been prepared for injection in chromatogra-
phy, within 8 hours44.
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The radioimmunoassay is another method used for 
detection of histamine. The double-antibody RIA can 
be used for studies of histamine release in both whole 
blood and cell supernatants. Nevertheless, it is not 
suitable for detection of histamine in plasma due to 
cross-reactivity with N-methyl-histamine. The latter is 
an enzymic product of histamine released from baso-
phils. The radioimmunoassay using succinyl-glycine 
as a reagent is the most sensitive method for detecting 
histamine in plasma45.
High histamine levels can be detected in allergic 
reactions, in mastocytosis and in various autoimmune 
disorders. 
Interferon-gamma
The ELISA method is a very sensitive method to deter-
mine IFN-γ46. Its sensitivity is less than 2pg/ml and it 
does not cross-react with other human interleukins and 
mediators. IFN-γ is a selective marker for tuberculosis 
pleurisy. That’s why the electrochemical detection of 
it was achieved, through a simple and direct electro-
chemical sensor. The method uses interferons RNA 
and DNA aptamers in order to detect it47. Moreover, 
immunohistochemical methods were used in order to 
detect IFN-γ and cells producing it. Such methods use 
a large panel of anti-IFNgamma antibodies to identify 
the IFNgamma-positive cells through immunoenzyme 
double staining. However, such method proves to be 
unreliable because of lack of specificity to stain T-
cells in situ. Information provided by immunochemis-
try must be interpreted with great attention48. 
The detection of human IFN-γ soluble receptors 
can be achieved through a dot blot assay using human 
IFN-γ labeled with 32P49.
A quite interesting indication to detect IFN-γ is in 
pleural fluid, in order to detect tuberculosis.
TNF-a
The production of TNF-a by human peripheral blood 
mononuclear cells can be measured through a radio-
immunoassay for human TNF-a. A rabbit antiserum 
against human recombinant TNF-a is used. The hu-
man TNF-a is labeled with Na125 . This method does 
not detect other interleukins and chemokines. Human 
mononuclear cells are exposed to different concen-
trations of lipopolysaccharide. Without an external 
stimuli, TNF concentrations were found below the 
detection limit, whereas as the lipopolysaccharide 
concentration increased, so did the concentration of 
TNF-a detected. The median concentration of TNF-a 
detected with this method was 2ng/ml50.
TNF-a can of course be measured using the 
ELISA method. The traditional technique uses the 
spectroscopic detection of a chromogen such as te-
tramethylbenzidine. Horseradish peroxidase bound 
to the detection antibody catalyses the oxidation of 
tetramethylbenzidine to generate colored products. 
However, the traditional colorimetric detection can be 
substituted with resonance Raman spectroscopy. The 
achievement is 50 times lower detection limits and the 
potential for multiplexed analysis is higher51.
Increased levels of TNF-a can be detected in pa-
tients with chronic obstructive pulmonary disease and 
with type 1 diabetes mellitus.
IL-1, IL-8
A very sensitive method for the quantitation of IL-1 is 
a solid-phase radioassay based. The method is based 
on the capability of IL-1 to bind the nitrocellulose-
immobilized IL-1 receptor solubilized from plasma 
membranes of a subclone of the human B cell lym-
phoma Raji. The assay has the ability to detect only 
the biologically active IL-1 and can detect low levels 
of human IL-1. Moreover, the sensitivity for IL-1a 
and IL-1b is even higher. The method can test large 
numbers of samples simultaneously52.
IL-8 can be quantitated through a sensitive sand-
wich ELISA. A polyclonal antibody to human IL-8 
was raised in rabbits and the IgG was isolated from 
the antisera using a protein A column. This method 
can detect even picogram quantities of IL-8. The low-
er sensitivity limit was found to be 84 pg/ml53.
IL-1 and IL-8 are found in high levels in a variety 
of chronic inflammatory diseases.
Nitric oxide
As well known, NO can be oxidated to NO2
- and NO
3
-. 
Nitrite and nitrate has been used as an index of en-
dothelial NO synthase activity. NO can be indirectly 
determinated through the spectrophotometric mea-
surement of nitrite and nitrate. Nitrate must first be 
reduced to nitrite and then nitrite is measured by the 
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Griess reaction. N2O3 is generated from nitrite and ni-
tric oxide and then reacts with sulfanilamide to yield 
a diazonium derivative. This reactive intermediate 
will interact with N-1-napthylethelene diamine to 
yield a colored diazo product that absorbs strongly at 
540nm.
Various fluorometric methods have been used for 
the detection of nitric oxide. One interesting method 
uses 2, 3-diaminonapthalene as an indicator for NO 
formation. 2, 3-diaminonapthalene reacts with N2O3 to 
yield the highly fluorescent product 2, 3-napthotriaz-
ole.
 
This assay has a high grade of specificity and sen-
sitivity. It can detect very low levels of 2, 3-napthotri-
azole and may be used for the quantitation of NO in 
physiological fluids and tissue culture media.
In any case, the detection and quantitation of NO 
remains a controversial issue. The mechanisms of de-
tection, as well as limitations of every methodology 
is very important to interprete the data given by every 
method54.
Chronic expression of NO is associated with vari-
ous carcinomas and inflammatory conditions such as 
multiple sclerosis, arthritis and ulcerative colitis.
conclusIon
All the factors mentioned above constitute very im-
portant tools for the clinical doctors, in order to diag-
nose rare diseases and understand the inflammatory 
processes that can take place in a pathophysiological 
level. However, the methods of their detection can 
be improved and provide useful information both in 
medical and research level.
ΠΕΡΙΛΗΨΗ: Η φλεγμονή είναι μια περίπλοκη διαδικασία που συμβαίνει μετά από κάποιο βλαπτικό ερέθισμα ή λοίμωξη. 
Κατά τη διάρκειά της, συμβαίνει μεγάλος αριθμός βιοχημικών αντιδράσεων και παθοφυσιολογικών αλλαγών. Αυτές οι 
διαδικασίες επάγονται από βιολογικά ενεργά μόρια που καλούνται μεσολαβητές ή χημιοκίνες. Τα μόρια αυτά παράγονται 
στο πλάσμα ή από κύτταρα κατά τη διάρκεια της φλεγμονώδους διαδικασίας. Κάποια από αυτά έχουν την ικανότητα να 
αλληλεπιδρούν μεταξύ τους. Σήμερα υπάρχουν διάφορες μέθοδοι ανίχνευσης και ποσοτικοποίησης τους. Οι τεχνικές αυτές 
εξελίσσονται και βελτιώνονται. Το ποια είναι η πιο κατάλληλη εξαρτάται από τον επιστημονικό σκοπό του κάθε ερευνητή.
Λέξεις Κλειδιά: Φλεγμονή, Μεσολαβητές, Χημιοκίνες, Βιολογικός προσδιορισμός.
Βιολογικοί παράγοντες φλεγμονής και μέθοδοι προσδιορισμού τους.
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